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OBJECTIVES: Liver function tests (LFTs) are routinely mea-
sured in primary care and often lead to further invasive and
expensive investigations. In patients with raised LFTs without
clinically apparent liver disease the appropriate level of follow-up
can be unclear. The aim was to derive and assess predictive
models to calculate the risk of liver disease diagnosis, with the
potential to facilitate and improve primary care management of
these patients. METHODS: A retrospective population-based
observational study followed-up all Tayside patients who had
incident LFTs in primary care, with no clinically obvious liver
disease (n = 95,977) from 1989 to 2003, to subsequent liver
disease diagnosis. The population was derived using strict inclu-
sion criteria and numerous databases. Record linkage of datasets
including biochemistry, hospital admissions, psychiatric admis-
sions, death registry and prescriptions enabled ascertainment of
risk factors and outcomes. A Weibull accelerated failure time
model was used to predict risk of liver disease diagnosis Potential
risk factors included each LFT, gender, age, deprivation, alcohol
dependency, drug dependency, history of cancer, IHD, stroke,
diabetes, and statin, NSAID and antibiotic use. The AIC was
used to assess goodness-of-ﬁt. The overall C-statistic measured
model discrimination, whilst the Grønnesby and Borgan method
assessed calibration. RESULTS: Due to non-proportional
hazards three models were developed. For the baseline-three
months model all LFTs and many LFT interactions were predic-
tive, as well as age, deprivation and methadone use. The three
month-one year model included three LFTs, with no interactions,
and cancer history and alcohol dependency. These models had
overall c-statistics of 0.85 and 0.72 for outcome of liver disease
respectively. Calibration was also good. CONCLUSIONS: We
have successfully developed and assessed the ﬁrst predictive
models for liver disease diagnosis in liver function tested primary
care patients. They can now be developed further into clinical
decision support systems for use in general practice.
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OBJECTIVES: To assess the prevalence of uncontrolled GORD
in UK primary care, describe the treatments used to achieve
symptom control and characterise the impact of reﬂux symptoms
on work productivity. METHODS: Data were collected on a
randomly selected sample of 308 patients who had visited their
primary care doctor due to reﬂux-related upper gastrointestinal
symptoms. Patients independently completed four patient-
reported outcome (PRO) questionnaires: Reﬂux Disease Ques-
tionnaire (RDQ), Extra-oesophageal Questions (XQS), GORD
Impact Scale (GIS) and the Work Productivity and Activity
Impairment GORD (WPAI-GORD) questionnaire. A clinician
assessment of GORD symptom severity and frequency was also
made during a medical consultation. RESULTS: Using the RDQ,
27% (84/308) of patients were identiﬁed with uncontrolled
GORD (deﬁned as moderate-to-severe GORD symptoms that
occurred at least 3 to 4 days a week). Age, sex, smoking status,
alcohol consumption, BMI and education were not predictive of
GORD symptom control. 55% (46/84) of patients with uncon-
trolled GORD were prescribed a proton pump inhibitor. Ome-
prazole and lansoprazole were prescribed for 80% (37/46) of
these patients. Absence from work and reduced productivity at
work due to uncontrolled GORD accounted for 7.6 lost hours a
week and was estimated to cost the UK economy an average of
€109/patient/week. CONCLUSIONS: Uncontrolled GORD is
prevalent in primary care despite the availability of effective
treatment strategies and guidance from the National Institute of
Health and Clinical Excellence (NICE). The wider adoption of
PRO questionnaires may help primary care doctors identify those
patients with GORD that are most severely affected. This could
lead to improvements in patient care and may beneﬁt health care
resource utilisation and work productivity.
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